Abstract
Beta-lactam intolerance, most of which is not IgE or even immunologically mediated even though it is commonly called an “allergy,” can be safely managed using the following seven steps:
-
1.
Avoid testing, re-challenging, or desensitizing individuals with histories of beta-lactam associated toxic epidermal necrolysis, Stevens–Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, severe hepatitis, interstitial nephritis, or hemolytic anemia.
-
2.
Avoid unnecessary antibiotic use, especially in the setting of viral infections.
-
3.
Expect new intolerances to be reported after 0.5 to 4 % of all antibiotic utilizations, dependent on gender and the specific antibiotic used.
-
4.
Expect a higher incidence of new intolerances in individuals with three or more medication intolerances already noted in their medical records.
-
5.
For individuals with an appropriate penicillin class antibiotic intolerance based on a history of anaphylaxis, urticaria, macular papular rashes, unknown symptoms, or symptoms not excluded in step one, proceed with penicillin skin testing. Skin test with penicilloyl-poly-lysine and native penicillin. If skin test is negative, proceed with an oral amoxicillin challenge. If skin test and oral challenge are negative, penicillin class antibiotics may be used. If skin test or oral challenge is positive, avoid penicillin class antibiotics. If skin test or oral challenge is positive, non-penicillin-beta-lactams may be used, unless there is a history of intolerance to a specific non-penicillin-beta-lactam, then avoid that specific non-penicillin-beta-lactam. If there is life-threatening infection that can only be treated with a penicillin class antibiotic, proceed with oral penicillin desensitization prior to any oral or parenteral penicillin use.
-
6.
For individuals with an appropriate non-penicillin-beta-lactam intolerance, avoid re-exposure to the beta-lactam implicated. An alternative beta-lactam may be used, ideally with different side chains. Penicillin allergy testing is not useful in the management of non-penicillin-beta-lactam intolerance. Non-penicillin-beta-lactam skin testing is not clinically useful and should not be done outside of a research setting. If the non-penicillin-beta-lactam implicated is needed to treat a life-threatening infection, proceed with desensitization.
-
7.
Be ready to treat anaphylaxis with all parenteral beta-lactam use.
Similar content being viewed by others
References
Little P, Stuart B, Moore M, on behalf of the GRACE consortium et al (2013) Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial. Lancet Infect Dis 13:123–129
Idsoe O, Guthe T, Willcox RR, De Weck AL (1968) Nature and extent of penicillin side-reactions, with particular reference to fatalities from anaphylactic shock. Bull Wld Hlth Org 38:159–188
Clemens JD, Ransohoff DF (1984) A quantitative assessment of pre-dental antibiotic prophylaxis for patients with metal-valve prolapse. J Chronic Dis 37:531–534
Lee P, Shanson D (2007) Results of a UK survey of fatal anaphylaxis after oral amoxicillin. J Antimicrob Chemother 60:1172–1179
Levine BB (1973) Antigenicity and cross-reactivity of penicillins and cephalosporins. J Inf Dis 128:s364–s366
Sogn DD, Evens R III, Shepard GM, Csale TB, Codemi J, Greenberger PA, Kohler PF, Saxon A, Summers RJ, VanArsdel PP, Massicot JG, Blackwelder WC, Levine BB (1992) Results of the National Institute of Allergy and Infectious diseases collaborative clinical trial to test the predictive value of skin testing with major and minor penicillin derivatives in hospitalized adults. Arch Intern Med 152:1025–1032
Caubet JC, Kaiser L, Lemaitre B, Fellay B, Gervaix A, Eigenmann PA (2011) The role of penicillin in benign skin rashes in childhood: a prospective study based on drug rechallenge. J Allergy Clin Immunol 127:218–222
Romano A, Gaeta F, Valluzzi R, Caruso C, Rumi G, Bousquet P (2010) IgE-mediated hypersensitivity to cephalosporins: cross-reactivity and tolerability of penicillins, monobactams, and carbapenems. J Allergy Clin Immunol 126:994–999
Buonomo A, Nucera E, De Pasquale T, Pecora V, Lombardo C, Sabato V, Colagiovanni A, Rizzi A, Aruanno A, Pascolini L, Patriarca G, Schiavino D (2011) Tolerability of aztreonam in patients with cell-mediated allergy to β-lactams. Int Arch Allergy Immunol 155:155–159
Liu X, Gao N, Qiao H (2011) Cephalosporin and penicillin cross-reactivity in patients allergic to penicillins. Int J Clin Pharmacol Ther 49:206–216
Antunez C, Blanca-Lopez N, Torres MJ, Mayorga C, Perez-Inestrosa E, Montanez MI, Fernandez T, Blanca M (2006) Immediate allergic reactions to cephalosporins: evaluation of cross-reactivity with a panel of penicillins and cephalosporins. J Allergy Clin Immunol 117:404–410
Guéant J, Guéant-Rodriguez R, Viola M, Valluzzi R, Romano A (2006) IgE-mediated hypersensitivity to cephalosporins. Curr Pharm Des 12:3335–3345
Baldo BA, Pham NH (2002) Immunoglobulin E binding determinants on beta-lactam drugs. Curr Opin Allergy Clin Immunol 2:297–300
DePestel D, Benninger M, Danziger L, LaPlante K, May C, Luskin A, Pichichero M, Hadley J (2008) Cephalosporin use in treatment of patients with penicillin allergies. J Am Pharm Assoc 48:530–540
Caimmi S, Caimmi D, Lombardi E, Crisafulli G, Franceschini F, Ricci G, Marseglia G (2011) Antibiotic allergy. Int J Immunopathol Pharmacol 24(3 Suppl):S47–S53
Solensky R (2003) Hypersensitivity reactions to beta-lactam antibiotics. Clin Rev Allergy Immunol 24:201–219
Yates AB (2008) Management of patients with a history of allergy to beta-lactam antibiotics. Am J Med 121:572–576
Lagace-Wiens P, Rubinstein E (2012) Adverse reactions to beta-lactam antimicrobials. Expert Opin Drug Saf 11:381–399
Ponvert C, Weilenmann C, Wassenberg J, Walecki P, Bourgeois M, de Blic J, Scheinmann P (2007) Allergy to betalactam antibiotics in children: a prospective follow-up study in retreated children after negative responses in skin and challenge tests. Allergy 62:42–46
Macy E, Poon KWT (2009) Self-reported antibiotic allergy incidence and prevalence: age and sex effects. Am J Med 122:778e1–e7
Macy E, Ho NJ (2012) Multiple drug intolerance syndrome: prevalence, clinical characteristics and management. Ann Allergy Asthma Immunol 108:88–93
Renn CN, Straff W, Dorfmuller A, Al-Masaoudi T, Merk HF, Sachs B (2002) Amoxicillin-induced exanthema in young adults with infectious mononucleosis: demonstration of drug-specific lymphocyte reactivity. Br J Derm 147:1166–1170
Viola M, Quaratino D, Gaeta F, Valluzzi RL, Caruso C, Rumi G, Romano A (2005) Allergic reactions to antibiotics, mainly beta-lactams: facts and controversies. Eur Ann Allergy Clin Immunol 37:223–229
Atanaskovic-Markovic M (2011) Educational case series: beta-lactam allergy and cross-reactivity. Ped Allergy Immunol 22:770–775
Torres MJ, Blanca M (2010) The complex clinical picture of beta-lactam hypersensitivity: penicillins, cephalosporins, monobactams, carbapenems, and clavans. Med Clin N Am 94:805–820
Palma-Carlos ML, Palma-Carlos AG, Medina M (2007) “In vivo” and “in vitro” tests in the diagnosis of beta-lactams allergy. Eur Ann Allergy Clin Immunol 39:157–161
Silva R, Cruz L, Botelho C, Castro E, Cadinha S, Castel-Branco MG, Rodrigues J (2009) Immediate hypersensitivity to penicillins with negative skin tests – the value of specific IgE. Eur Ann Allergy Clin Immunol 41:117–119
Fontaine C, Mayorga C, Bousquet PJ, Arnoux B, Torres MJ, Blanca M, Demoly P (2007) Relevance of the determination of serum-specific IgE antibodies in the diagnosis of immediate beta-lactam allergy. Allergy 62:47–52
Torres MJ, Blanca M (2003) Letter to the editor. Allergy 58:452
Bousquet PJ, Pipet A, Bousquet-Rouanet L, Demoly P (2007) Oral challenge are needed in the diagnosis of beta-lactam hypersensitivity. Clin Exp Allergy 38:185–190
Bousquet PJ, Kvedariene V, Co-Minh HB, Martins P, Rongier M, Arnoux B, Demoly P (2007) Clinical presentation and time course in hypersensitivity reactions to beta-lactams. Allergy 62:872–876
Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology (2010) Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol 105:259–273, 273e1-e78
Adkinson NF Jr, Thompson WL, Maddrey WC, Lichtenstein LM (1971) Routine use of penicillin skin testing on an inpatient service. N Engl J Med 285:22–24
Macy E, Schatz M, Lin C, Poon KWT (2009) The falling rate of positive penicillin skin tests from 1995 to 2007. Permanente J 13:12–18
Jost BC, Wedner HJ, Bloomberg GR (2006) Elective penicillin skin testing in a pediatric outpatient setting. Ann Allergy Asthma Immunol 97:807–812
Park M, Markus P, Matesic D, Li JTC (2006) Safety and effectiveness of a preoperative allergy clinic in decreasing vancomycin use in patients with a history of penicillin allergy. Ann Allergy Asthma Immunol 97:681–687
Lin E, Saxon A, Riedl M (2010) Penicillin allergy: value of including amoxicillin as a determinant in penicillin skin testing. Int Arch Allergy Immunol 152:313–318
Macy E, Ngor EW (2013) Safely diagnosing clinically significant penicillin allergy using only penicilloyl-poly-lysine, penicillin, and oral amoxicillin. J Allergy Clin Immunol In Practice (in press)
Macy E, Burchette RJ (2002) Oral antibiotic adverse reactions after penicillin testing: multi-year follow-up. Allergy 57:1151–1158
Pichichero ME, Casey JR (2007) Safe use of selected cephalosporins in penicillin-allergic patients: meta-analysis. Otolaryngol Head Neck Surg 136:340–347
Macy E, Ho NJ (2011) Adverse reactions associated with therapeutic antibiotic use after penicillin skin testing. Perm J 15:31–37
Macy E, Goldberg B, Poon KWT (2010) Use of commercial anti-penicillin-IgE FEIAs to diagnose penicillin allergy. Ann Allergy Asthma Immunol 105:136–141
Raja A, Lindsell CJ, Bernstein JA, Codispoti CD, Moellman JJ (2008) The use of penicillin skin testing to assess the prevalence of penicillin allergy in an emergency department setting. Ann Emerg Med 54:72–77
Romano A, Bousquet-Rouanet L, Viola M, Gaeta F, Demoly P, Bousquet PJ (2009) Benzylpenicillin skin testing is still important in diagnosing immediate hypersensitivity reactions to penicillin. Allergy 64:249–253
Torres MJ, Romano A, Blanca-Lopez N, Dona I, Canto G, Ariza A, Aranda A, Montanez MI, Mayorga C, Blanca M (2011) Immunoglobulin E-mediated hypersensitivity to amoxicillin: in vivo and in vitro comparative studies between an injectable therapeutic compound and a new commercial compound. Clin Exp Allergy 41:1595–1601
Mark MA, Koch CA, Klemawesch P, Joshi A, Li JT (2010) Increased adverse drug reactions to cephalosporins in penicillin allergy patients with positive penicillin skin test. Int Arch Allergy Immunol 153:268–273
Park MA, Matesic D, Markus PJ, Li JTC (2007) Female sex as a risk factor for penicillin allergy. Ann Allergy Asthma Immunol 99:54–58
Macy E (2011) The clinical evaluation of penicillin allergy: what is necessary, sufficient, and safe given the materials currently available? Clin Exp Allergy 41:1498–1501
Macy E, Richter PK, Falkoff R, Zeiger RS (1997) Skin testing with penicilloate and penilloate prepared by an improved method: amoxicillin oral challenge in patients with negative skin test responses to penicillin reagents. J Allergy Clin Immunol 100:586–591
Macy E (2011) Penicillin allergy might not be very common in subjects with cephaloszorin allergy. J Allergy Clin Immunol 127:1638
Romano A, Gaeta F, Valluzzi RL, Caruso C, Rumi G, Bousquet PJ (2011) Reply. J Allergy Clin Immunol 127:1638–1639
Macy E, Mangat R, Burchette RJ (2003) Penicillin skin testing in advance of need: multiyear follow-up in 568 test result-negative subjects exposed to oral penicillins. J Allergy Clin Immunol 111:1111–1115
Patriarca G, Schiavino D, Lombardo C, Altomonte G, De Cinti M, Buonomo A, Nucera E (2008) Tolerability of aztreonam in patients with IgE-mediated hypersensitivity to beta-lactams. Int J Immunopathol Pharmacol 21:375–379
Buonomo A, Nucera E, De Pasquale T, Pecora V, Lombardo C, Sabato V, Colgiovanni A, Rizzi A, Aruanno A, Pascolini L, Patriarca G, Schiavino D (2011) Tolerabilty of aztreonam in patients with cell-mediated allergy to beta-lactams. Int Arch Allergy Immunol 155:155–159
Acknowledgments
Funded by the Kaiser Permanente Health Care Program. The authors have no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Macy, E., Ngor, E. Recommendations for the Management of Beta-Lactam Intolerance. Clinic Rev Allerg Immunol 47, 46–55 (2014). https://doi.org/10.1007/s12016-013-8369-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12016-013-8369-8